Mammary Gland Morphogenesis and Breast Cancer

乳腺形态发生与乳腺癌

基本信息

  • 批准号:
    8446157
  • 负责人:
  • 金额:
    $ 33.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2015-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): More than 90% of breast cancers arise from epithelial cells or from progenitors with stem cell properties. Cell polarity is essential for stem cell asymmetric divisions, and failures in polarization can result in tumorigenesis. The Par polarity proteins are key regulators of asymmetric cell division. Par proteins also control polarization of differentiated epithelial cells. Yet the molecular mechanisms underlying polarity in mammary morphogenesis and the role of Par proteins in breast cancer remain largely unknown. We have developed methods that facilitate the study of mammary morphogenesis and tumorigenesis. To manipulate gene expression in mammary glands, stem cells are transduced with lentivirus, and mammary glands are regenerated in host mice from these cells. Lentiviral transduction enables rapid analysis of molecular mechanism through a knock-down/knock-in approach. Using these methods, an essential role for the Par3 polarity protein in mammary morphogenesis was discovered. In addition, silencing of Par3 potentiated tumor growth and metastasis. The goals are as follows: 1. How does Par3 regulate stem/progenitor self-renewal and differentiation during mammary gland morphogenesis? In the absence of Par3, atypical protein kinase C (aPKC) is mislocalized from the luminal apical surface. A knock-down/knock-in strategy will be used to ask if fate determination can be rescued by apically-tethered aPKC and by Par3 mutants. A novel miRNA sensor will be used to identify stem cells and to ask if Par3 is required for asymmetric division. Differential functions of Par3 in luminal and myoepithelial cells will be tested using new methods for cell-type specific RNAi silencing. 2. How does Par3 function to suppress tumor growth and metastasis? Preliminary data suggest that Par3 might limit mammary cell proliferation by suppressing Rac activity in the NICD cells, while separately controlling cell lineage determination and metastasis through aPKC. Lentivirus will be used to manipulate gene expression in primary cells, which are tested using the in vivo transplant model, tail vein injections, and in vitro mammosphere cultures. 3. Can we identify multiple additional metastasis suppressors/inducers by in vivo screening?. Mammary stem cells from ErbB2 mice will be infected with pooled lentiviruses that express a library of cDNAs, then implanted into cleared fat pads of wild type host mice. The viruses also express a red fluorescent protein. RFP-positive lung metastases will be isolated and screened by PCR to identify the cDNA associated with each metastatic colony. Positives will be prioritized based on expression patterns in human tumors for mechanistic studies. Together, these studies will provide insights into polarity protein signaling during stem/progenitor cell self-renewal and lineage determination, and identify new players in mammary tumor metastasis.
描述(由申请人提供):超过90%的乳腺癌起源于上皮细胞或具有干细胞特性的祖细胞。细胞极性对于干细胞的不对称分裂是必不可少的,并且极化失败可导致肿瘤发生。Par极性蛋白是细胞不对称分裂的关键调节因子。Par蛋白还控制分化的上皮细胞的极化。然而,乳腺形态发生中极性的分子机制和Par蛋白在乳腺癌中的作用仍然是未知的。我们已经开发出了促进乳腺形态发生和肿瘤发生研究的方法。为了操纵乳腺中的基因表达,用慢病毒转导干细胞,并在宿主小鼠中从这些细胞再生乳腺。慢病毒转导能够通过敲低/敲入方法快速分析分子机制。使用这些方法,发现了Par 3极性蛋白在乳腺形态发生中的重要作用。此外,Par 3的沉默增强肿瘤生长和转移。具体目标如下:1. Par 3如何调节乳腺形态发生过程中干/祖细胞的自我更新和分化?在不存在Par 3的情况下,非典型蛋白激酶C(aPKC)从管腔顶端表面错误定位。敲低/敲入策略将用于询问命运决定是否可以通过顶端系留的aPKC和Par 3突变体来挽救。一种新的miRNA传感器将用于识别干细胞,并询问Par 3是否是不对称分裂所必需的。Par 3在管腔和肌上皮细胞中的差异功能将使用细胞类型特异性RNAi沉默的新方法进行测试。2. Par 3是如何抑制肿瘤生长和转移的?初步数据表明,Par 3可能通过抑制NICD细胞中的Rac活性来限制乳腺细胞增殖,同时通过aPKC单独控制细胞谱系确定和转移。慢病毒将用于操纵原代细胞中的基因表达,使用体内移植模型、尾静脉注射和体外乳腺球培养物对原代细胞进行检测。3.我们能否通过体内筛选鉴定多种额外的转移抑制剂/诱导剂?来自ErbB 2小鼠的乳腺干细胞将用表达cDNA文库的混合慢病毒感染,然后植入野生型宿主小鼠的清洁脂肪垫中。这些病毒还表达红色荧光蛋白。将分离RFP阳性肺转移瘤,并通过PCR进行筛选,以鉴定与每个转移集落相关的cDNA。将根据人肿瘤中的表达模式对阳性进行优先排序,以进行机制研究。总之,这些研究将为干/祖细胞自我更新和谱系确定过程中的极性蛋白信号传导提供见解,并确定乳腺肿瘤转移的新参与者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IAN G MACARA其他文献

IAN G MACARA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IAN G MACARA', 18)}}的其他基金

Cancer and Context
癌症与背景
  • 批准号:
    10221624
  • 财政年份:
    2015
  • 资助金额:
    $ 33.87万
  • 项目类别:
Cancer and Context
癌症与背景
  • 批准号:
    8955798
  • 财政年份:
    2015
  • 资助金额:
    $ 33.87万
  • 项目类别:
Cancer and Context
癌症与背景
  • 批准号:
    9315574
  • 财政年份:
    2015
  • 资助金额:
    $ 33.87万
  • 项目类别:
Cancer and Context
癌症与背景
  • 批准号:
    9982211
  • 财政年份:
    2015
  • 资助金额:
    $ 33.87万
  • 项目类别:
Cancer and Context
癌症与背景
  • 批准号:
    9751082
  • 财政年份:
    2015
  • 资助金额:
    $ 33.87万
  • 项目类别:
Mammary Gland Morphogenesis and Breast Cancer
乳腺形态发生与乳腺癌
  • 批准号:
    8215927
  • 财政年份:
    2010
  • 资助金额:
    $ 33.87万
  • 项目类别:
Mammary Gland Morphogenesis and Breast Cancer
乳腺形态发生与乳腺癌
  • 批准号:
    8637935
  • 财政年份:
    2010
  • 资助金额:
    $ 33.87万
  • 项目类别:
Mammary Gland Morphogenesis and Breast Cancer
乳腺形态发生与乳腺癌
  • 批准号:
    8135217
  • 财政年份:
    2010
  • 资助金额:
    $ 33.87万
  • 项目类别:
Mammary Gland Morphogenesis and Breast Cancer
乳腺形态发生与乳腺癌
  • 批准号:
    7982626
  • 财政年份:
    2010
  • 资助金额:
    $ 33.87万
  • 项目类别:
MECHANISMS OF CELL POLARITY ESTABLISHMENT
细胞极性建立机制
  • 批准号:
    7932406
  • 财政年份:
    2009
  • 资助金额:
    $ 33.87万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 33.87万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 33.87万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 33.87万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 33.87万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 33.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 33.87万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 33.87万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 33.87万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 33.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 33.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了